Milestone Pharmaceuticals won FDA approval for a new nasal-spray medicine to treat episodes of paroxysmal supraventricular ...

Sanofi flagged a second delay to an FDA decision for its experimental multiple sclerosis drug and reported disappointing ...

More on AI: When it comes to folding AI tools into mammograms, AI firms believe there’s even more knowledge to be gleaned ...

Researchers hoped they had finally found a way to get gene therapies past the blood-brain barrier. Then the first patient ...

Siddhartha Mukherjee, oncologist and author of “The Emperor of All Maladies,” asks: What if we change what a tumor can eat?

After years of counseling families through loss, I am still moved by their strength. I carry with me Eleanor’s prayer, ...

A new generation of AI algorithms aim to go beyond detecting cancers to predicting risk for cardiovascular diseases.

To encourage robust, good-faith discussion about issues raised in First Opinion essays, STAT publishes selected Letters to ...

Trump's order to block state AI laws could help the tech industry but hurt health systems looking to adopt AI safely, and ...

Zoliflodacin, which will be marketed under the name Nuzolvence, is the first new drug to uniquely target gonorrhea infections ...

Amid fears of superbugs, the sale of medically important antibiotics given to food-producing livestock rose dramatically last ...

The federal government has sent a record $16 billion to health insurers that sell Medicare drug plans, a flashing red sign ...